key articles
Effect of Saw Palmetto Soft Gel Capsule on Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Friday, 18 January 2008 - Shi et al. (2008) determined the effect of ProstataplexTM in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
A total of 92 Chinese men between 49 and 75 years old...
Authors: Shi et al.
The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms
Thursday, 17 January 2008 - Roehrborn et al. (2008) investigated whether therapy combining dutasteride with tamsulosin is more effective than either monotherapy alone for improving symptoms and long-term outcomes in men with...
Authors: Roehrborn et al.
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
Tuesday, 8 January 2008 - The ongoing REDUCE (REduction by DUtasteride of prostate Cancer Events) trial is a 4-year, phase 3, placebo-controlled study to determine if daily dutasteride 0.5mg reduces the risk of biopsy detectable...
Authors: Nickel et al.
Relationship of Lifestyle and Clinical Factors to Lower Urinary Tract Symptoms: Results from Boston Area Community Health Survey
Wednesday, 26 December 2007 - Because lifestyle factors and comorbidities can influence lower urinary tract symptoms (LUTS) by sex and race/ethnicity differently, Litman et al. (2007) studied these associations in the Boston Area...
Authors: Litman et al.
A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey
Friday, 7 December 2007 - Herschorn et al. (2007) analyzed the prevalence of lower urinary tract symptoms (LUTS) and urinary incontinence (UI) in Canada, using a cross-Canada telephone survey, as there is a wide discrepancy in...
Authors: Herschorn et al.
Aminocyclohexylsulfonamides for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms
Friday, 7 December 2007 - Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) can be effectively treated by α1 adrenergic receptor antagonists, but these drugs also produce side effects that are related to...
Authors: Chiu et al.
Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third national health and nutrition examination survey
Monday, 3 December 2007 - Benign growth of the prostate is thought to contribute to lower urinary tract symptoms (LUTS) in older men. It is, however, unclear which factors induce prostate growth in these men. Rohrmann et al....
Authors: Rohrmann et al.
Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot Study
Thursday, 22 November 2007 - Gacci et al. (2007) assessed urodynamic changes after vardenafil administration in spinal cord injured male patients on oxybutynin treatment.
The authors did a single center, randomized,...
Authors: Gacci et al.
Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms
Sunday, 11 November 2007 - Lower urinary tract symptoms (LUTS) are highly prevalent among men. However, not all men with LUTS have urodynamically confirmed bladder outlet obstruction. Overactive bladder symptoms are often caused...
Authors: Kuo
Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS
Thursday, 8 November 2007 - Lower urinary tract (LUT) smooth muscle can be relaxed by drugs that increase intracellular concentrations of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Both of...
Authors: Andersson et al.
